Frances R. Frankenburg, MD

  • 12Articles
  • 61.3KReads
  • 1996–2024Active
  • 10Collaborators
  • 198Citations

About

Frances R. Frankenburg, MD, is affiliated with McLean Hospital in Belmont, Massachusetts, and Boston University School of Medicine in Boston, Massachusetts. Dr. Frankenburg has contributed to Psychiatrist.com from 1996 to 2024, authoring 12 articles on topics including addiction, bipolar disorder, mood disorders, neurodevelopmental conditions, neuroleptic malignant syndrome, psychiatry, and suicide. Frequent collaborators include Mary C. Zanarini, Garrett M. Fitzmaurice, Christina M. Temes, Isabel V. Glass, and Douglas Kalunian.

Publications

JCP
Symptomatic Remission and Overall Recovery From BPD
Original Research

Symptomatic Remission and Overall Recovery From BPD

October 23, 2024

Over 24 years, patients with BPD were significantly slower to achieve remission or recovery than patients with other personality disorders. Ultimately, however, both groups achieved similarly high rates of...
, , , et al
JCP
Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time
Original Research

Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time

August 7, 2024

Findings suggest that the absence of substance use disorders is the strongest predictor of achieving recovery from BPD.
, , , et al
JCP
Smoking in Borderline Patients
Original Research

Smoking in Borderline Patients

November 8, 2023

This study assessed predictors of smoking in borderline personality disorder and compared smoking prevalence in recovered vs non-recovered patients.
, , , et al
JCP
Original Research

Deaths in Borderline Personality Disorder Patients

January 22, 2019

Borderline personality disorder (BPD) is associated with increased suicidality, but less is known about other forms of premature death in individuals with BPD. Read this article to learn how...
, , , et al
JCP
Original Research

The Use of Prescription Opioid Medication by Patients With Borderline Personality Disorder and Axis II Comparison Subjects: A 10-Year Follow-Up Study

January 7, 2014

, ,
JCP
Letter to the Editor

Folate Supplementation: Is It Safe and Effective?

May 13, 2009

JCP
Original Research

The Association Between Borderline Personality Disorder and Chronic Medical Illnesses, Poor Health-Related Lifestyle Choices, and Costly Forms of Health Care Utilization

December 15, 2004

,
JCP
Original Research

A Preliminary, Randomized Trial of Fluoxetine, Olanzapine, and the Olanzapine-Fluoxetine Combination in Women With Borderline Personality Disorder

July 1, 2004

, ,
JCP
Original Research

Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years

January 1, 2004

, , , et al
JCP
Original Research

Divalproex Sodium Treatment of Women With Borderline Personality Disorder and Bipolar II Disorder: A Double-Blind Placebo-Controlled Pilot Study

May 12, 2002

,
JCP
Original Research

Olanzapine Treatment of Female Borderline Personality Disorder Patients: A Double-Blind, Placebo-Controlled Pilot Study

November 1, 2001

,
JCP
Letter to the Editor

Cardiorespiratory Problems With Clozapine

November 15, 1996

,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe